Detalhe da pesquisa
1.
Evolutionary histories of breast cancer and related clones.
Nature
; 620(7974): 607-614, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37495687
2.
Non-surgical ablation for breast cancer: an emerging therapeutic option.
Lancet Oncol
; 25(3): e114-e125, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423057
3.
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.
Br J Cancer
; 130(6): 1023-1035, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238427
4.
Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis.
Breast Cancer Res Treat
; 204(2): 261-275, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38123790
5.
Fosfomycin as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia: A case series and review of the literature.
J Infect Chemother
; 30(4): 352-356, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922987
6.
Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims database.
Breast Cancer Res Treat
; 197(2): 435-447, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36414795
7.
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Breast Cancer Res Treat
; 202(3): 485-496, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676450
8.
An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9.
BMC Cancer
; 23(1): 438, 2023 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37179317
9.
Ultrafast Dynamic Contrast-Enhanced MRI of the Breast: From Theory to Practice.
J Magn Reson Imaging
; 2023 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085134
10.
Real-World Patient Characteristics, Treatment Patterns, and Outcomes of HR+, HER2- Early Breast Cancer Patients in Japan: An Analysis with National Database(NDB).
Gan To Kagaku Ryoho
; 50(12): 1283-1294, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247066
11.
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 23(5): 636-649, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405087
12.
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(1): 74-84, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387497
13.
Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.
Cancer Sci
; 112(8): 3338-3348, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34036661
14.
Exploring Primordial Black Holes from the Multiverse with Optical Telescopes.
Phys Rev Lett
; 125(18): 181304, 2020 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196269
15.
Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes.
Int J Clin Oncol
; 24(6): 608-613, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982153
16.
Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm.
Breast Cancer Res Treat
; 172(3): 611-618, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194511
17.
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.
Breast Cancer Res Treat
; 171(3): 675-683, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29971625
18.
[â ¡. POTENT Trial].
Gan To Kagaku Ryoho
; 49(12): 1317-1320, 2022 12.
Artigo
em Japonês
| MEDLINE | ID: mdl-36539242
19.
Evidence of Halo Assembly Bias in Massive Clusters.
Phys Rev Lett
; 116(4): 041301, 2016 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26871319
20.
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients.
Int J Clin Oncol
; 20(4): 709-22, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25666483